Main Session
Sep
30
QP 40 - Personalized Therapy and Special populations in Head and Neck Cancer
1240 - Prospective Evaluation of Daily Online Adaptive Radiotherapy with 1mm PTV Margins in High Risk HPV Negative Head and Neck Cancer
Presenter(s)
Harjot Bajwa, MD - American Oncology Institute, Hyderabad,